← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 1, 1995Last known activity
Oct 5, 2021
Timeline
Drugs by trial phase (8 distinct, 11 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Approved for
Marketed drugs (1)
Recent trials (11)
- NCT05190991CollaboratorPhase 2Oct 5, 2021
- NCT05092776CollaboratorPhase 2Apr 29, 2021
- NCT05673902CollaboratorPhase 3Dec 11, 2020
- NCT04692766CollaboratorPhase 2/Phase 3Feb 12, 2020
- NCT04067492CollaboratorPhase 2Mar 26, 2018
- NCT01931748Lead sponsorPhase 3Apr 1, 2013
- NCT01808300Lead sponsorPhase 1Feb 1, 2013
- NCT00135018Overall official - principal investigatorPhase 2Feb 1, 2006
- NCT00193661CollaboratorPhase 2Aug 1, 2002
- NCT00193700CollaboratorPhase 1Aug 1, 2002
- NCT00002444Lead sponsorPhase 1Oct 1, 1995
Details
- Founded
- Seoul, KR Jan 1, 1990
- Last known activity
- Oct 5, 2021
Designations held
- Priority review